EMT is accompanied by reduced expression of epithelial markers, such as E-cadherin (E-cad), increased mesenchymal markers, such as vimentin [11], and activation of transcription factors, such as SNAI1 [12, 13] in cancer cells. The gene discussed is CDH1; the disease is cancer.